Vivos (RDGL) FCF Margin (QoQ) (2011 - 2025)
Vivos (RDGL) FCF Margin (QoQ) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.03 Bn | 6.27 Bn |
| 2 | Stryker | 128.82 Bn | 125.95 Bn | 3.81 Bn |
| 3 | Medtronic | 108.46 Bn | 99.24 Bn | 6.41 Bn |
| 4 | Boston Scientific | 68.25 Bn | 66.79 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 47.64 Bn | 43.97 Bn | 1.29 Bn |
| 6 | Dexcom | 28.55 Bn | 27.43 Bn | 750.30 Mn |
| 7 | GE HealthCare Technologies | 28.51 Bn | 26.22 Bn | 1.98 Bn |
| 8 | Smith & Nephew | 26.96 Bn | 26.39 Bn | - |
| 9 | Koninklijke Philips | 25.42 Bn | 22.29 Bn | 2.07 Bn |
| 10 | Vivos | 27.30 Mn | 25.74 Mn | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.22 Mn |
| Sep 30, 2025 | -2.04 Mn |
| Jun 30, 2025 | -232,826.00 |
| Mar 31, 2025 | 772,587.00 |
| Dec 31, 2024 | 69,747.00 |
| Sep 30, 2024 | -749,246.00 |
| Jun 30, 2024 | 517,750.00 |
| Sep 30, 2023 | 166,564.00 |
| Jun 30, 2023 | 5,778.00 |
| Mar 31, 2023 | -55,974.00 |
| Dec 31, 2022 | 1,944.00 |
| Sep 30, 2022 | -272,374.00 |
| Jun 30, 2022 | 132,643.00 |
| Dec 31, 2019 | -1.46 Mn |
| Sep 30, 2016 | 9.98 Mn |
| Jun 30, 2016 | -838,466.00 |
| Jun 30, 2014 | -26,804.00 |
| Mar 31, 2013 | -182,115.00 |
| Dec 31, 2012 | 59,976.00 |
| Sep 30, 2012 | -20,911.00 |